Saab AB SAAB B ORD SHS/ SE0021921269 /
5/24/2024 6:36:55 PM | Chg. - | Volume | Bid2:42:32 PM | Ask2:42:32 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
249.05SEK | - | 15,127 Turnover: 2.8 mill. |
226.10Bid Size: 2,000 | 235.50Ask Size: 2,000 | 123.45 bill.SEK | 0.69% | 36.36 |
GlobeNewswire
6/3
uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational G...
Newsfile Corp
4/11
Tor Holding and ELIE SAAB Announce Partnership for Dual Real Estate Debut in Turkey
GlobeNewswire
4/4
Schneider Electric announces global winners of second edition of its Sustainability Impact Awards
GlobeNewswire
4/3
SK hynix announces semiconductor advanced packaging investment in Purdue Research Park
GlobeNewswire
12/19/2023
uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of ...
GlobeNewswire
11/29/2023
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for...
GlobeNewswire
11/13/2023
Bombardier Defense Delivers Seventh Global Aircraft for Saab’s GlobalEye Airborne Surveillance Solut...
GlobeNewswire
11/3/2023
Candel Therapeutics Announces Initial Positive Interim Data from Randomized Phase 2 Clinical Trial o...